Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Ensysce Biosciences Inc (Ensysce Biosciences) is a biotechnology company. It offers proprietary abuse-resistant opioid prodrug technology. The company’s pipeline products include PF614- TAAP oxycodone for pain and respiratory diseases, PF8001 / PF8026- TAAP amphetamine to deter prescription drug abuse at the molecular level , OUD is to abuse-deterrent technology for Opioid Use Disorder. The company offers services such as clinical programs, preclinical programs, TAAP technology, pain medications, drug delivery, MPAR technology, proprietary prodrug technology, abuse resistant technology among others. It provides its products and services to the healthcare, medical and pharmaceutical sectors. Ensysce Biosciences is headquartered in San Diego, California, the US.
Headquarters
United States of America
Address
7946 Ivanhoe Avenue, Suite 201, La Jolla, California, 92037
Website
ensysce.com
Telephone
1 858 2634196
No of Employees
7
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ENSC (NASD)
Revenue (2022)
$2.2M
-11.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
56.1%
(2022 vs 2021)
Market Cap*
$4.8M
Net Profit Margin (2022)
XYZ
50.3%
(2022 vs 2021)
* As of and is in US$
Products and Services
| Products | Services |
|---|---|
| Pipeline products: | Services |
| PF614- TAAP oxycodone | Clinical Programs |
| Respiratory Diseases | Preclinical Programs |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In November, the company entered into an agreement with OncoZenge to accelerate the launch of BupiZengeTM in the United States. |
| 2022 | Contracts/Agreements | In August, the company entered into a partnership with Quotient Sciences Ltd to support the development and clinical testing of PF614-MPAR. |
| 2021 | Acquisitions/Mergers/Takeovers | In July, the company merged with Leisure Acquisition Corp, a blank check company. |
Competitor Comparison
| Key Parameters | Ensysce Biosciences Inc | Sagimet Biosciences Inc | 3T Biosciences Inc | AB Biosciences Inc | Abcombi Biosciences Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | La Jolla | San Mateo | South San Francisco | Allston | Buffalo |
| State/Province | California | California | California | Massachusetts | New York |
| No. of Employees | 7 | 10 | - | - | - |
| Entity Type | Public | Public | Private | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Bob Gower | Chairman | Executive Board | - | - |
| Lynn Kirkpatrick | President; Chief Executive Officer; Director | Executive Board | 2009 | 66 |
| Dave Humphrey | Treasurer; Secretary; Chief Financial Officer | Senior Management | 2021 | 54 |
| Jeffrey Millard | Chief Operating Officer | Senior Management | 2019 | 47 |
| William Schmidt | Chief Medical Officer | Senior Management | 2016 | 71 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer